Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Healthy × Interviews as Topic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 22 Prostatic Neoplasms 10 Breast Neoplasms 10 Colorectal Neoplasms 9 Ovarian Neoplasms 6 Lung Neoplasms 5 Hematologic Neoplasms 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Pain 2 Mouth Neoplasms 2 Low Anterior Resection Syndrome 2 Fatigue 2 Endometrial Neoplasms 2 Depression 2 Colonic Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Total Exenteration 1 Tobacco Use Cessation 1 Thyroid Neoplasms 1 Stomach Neoplasms 1

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Olive Oil 1 Midazolam 1 Interviews as Topic 1 Cyclosporine 1 Control Groups 1 Blood Specimen Collection 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02378363 2015-03-04

RISCOLAIRE

Institut de Cancérologie de la Loire

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡